Alex Rogers is a visionary entrepreneur, political activist and the founder of several influential cannabis businesses over the past 30 years. He is the mastermind behind the International Cannabis Business Conference (ICBC)—the first and largest international business conference producing events across multiple continents. He is renowned worldwide for connecting elite industry leaders and also serves as the CEO of the members-only Talman House, created to connect entrepreneurs seeking capital with investors ready to deploy capital in Europe’s emerging industry. Alex Rogers also played a crucial role in professionalizing and mainstreaming the United States’ cannabis industry by founding one of the most popular medical cannabis clinics, which became the first to advertise medical cannabis on network television. A Magna Cum Laude graduate in Political Science, Rogers’ passion is leveraging his influence to shape cannabis policy globally. Alex has successfully advocated for progressive cannabis reform on the global stage, including in California, Oregon, Germany and Slovenia. His foundational work with legendary pioneer Jack Herer and his incredible influence globally have cemented Rogers’ legacy as both a successful international cannabis entrepreneur and a global policy influencer.

Jamie Pearson has been a highly respected leader in the cannabis industry for over a decade. Her “in the trenches” operational success and deep, global relationships led her to be coined “Wonder Woman” in the 2023 Women of Influence issue of Cannabis Now Magazine. Fluent in German, Jamie spent decades in the global real estate investment and finance world on three continents. She currently sits on the advisory boards of Dope Drinks, Marley One, Cellotex Dev Ltd, Global Cannabis Network Collective (GCNC), Lift & Co, and Alpen Group AG.

Jamie founded and leads The New Holland Group, a global consulting firm serving clients with international business development & strategy, seed to sale operations, branding & marketing, effective capital raising, executive coaching, cross border IP licensing, celebrity partnerships, buy & sell side M&A, and financial turnarounds. Client referrals have been New Holland Group’s only source of business and business is booming!

Before New Holland Group, Jamie spent seven years, including three as the President & CEO, of Bhang Inc. [CSE:BHNG] one of the world’s most-awarded and recognized cannabis edible brands, famous for its infused chocolate bars. She led the company’s diverse executive team, managed the “expansion through licensing” plan, ran the capital markets division, and was the face of the brand – catapulting Bhang from a California favorite to a multi-state and multi-national phenomenon. When Jamie exited Bhang the brand had been distributed in 7 US states and 10 countries through licensing deals with the likes of Trulieve, [CSE:TRUL], Indiva [TSX:NDVA] and Origin House [CSE:OH] (now Cresco). Jamie served four years as the Vice Chairman of Bhang’s Board and served on the Board’s audit committee.
Jamie is a popular speaker with competence in the areas of global expansion, ESG, IP & brand licensing, real estate acquisition, creative deal structuring, celebrity partnerships, business development, and leadership. Jamie can be reached at jamie@new-holland.group.

As Partner at Verdant Strategies, Mike Goral J.D., LL.M advances the firm’s mission of turning complexity into clarity for cannabis operators, investors, and advisors. Based in New Jersey, he plays a pivotal role in Verdant’s expanding East Coast presence, bringing both regulatory expertise and a relationship-first approach to client success.

Recognized as a leading authority in the cannabis industry, Mike is the author of Multistate Cannabis Taxation for Thomson Reuters, the definitive resource on the subject. With more than a decade dedicated exclusively to cannabis operators, he has guided companies through tax, accounting, and operational complexities while helping many scale from single dispensaries into thriving multi-state organizations.

Mike’s proven track record of advising clients across legal cannabis markets strengthens Verdant’s practice and ensures operators have the financial clarity and strategic insight needed to scale with confidence.

Michael Sassano is a highly influential executive who drives a unique dual strategy in the pharmaceutical cannabis space. As Founder and Chairman of Somaí Pharmaceuticals through Green Rush Partners and Interim CEO of Somaí, he directs a leading, globally-focused EU-GMP vertically integrated Multi-Country Operator (MCO). Somaí maintains market leadership with the largest and most advanced EU-GMP-certified cannabinoid extract portfolio and high-end craft indoor flowers, ensuring the broadest global distribution reach. This leadership extends to the premium consumer segment, where Somaí strategically manufactures and serves as the global distributor for renowned brands like Cookies, AirPro, Sherbinskis, and Jack Herer.

Chief Inspiration Officer – Sullivan Adventures LLC
Partner: New Holland Group
Keynote Speaker – Advisor – Investor

Jeanne M. Sullivan is a passionate about delivering ideas – information – and inspiration to entrepreneurs – Sullivan has been early to various sectors – investing in tech infrastructure, the internet wave, cloud-based computing, data aggregation and early in the cannabis sector. She is thrilled to leverage years in this industry and support entrepreneurs seeking European-based cannabis opportunities.
She co-founded an early-stage cannabis fund and is a frequent speaker on the conference circuit. Sullivan has been part of the Arcview Group and Arcview Ventures since 2015.

Jeanne co-founded StarVest Partners, a venture capital firm in NYC raising $400 million to invest in tech-enabled business services companies. Prior to her venture experience with StarVest and Olivetti Ventures, Jeanne gained her operating experience with AT&T and Bell Labs while serving in product and industry marketing roles.

Ms. Sullivan has served on the board of multiple technology and cannabis companies and has extensive experience creating “go to market” plans for growth and expansion stage companies. Her expertise also includes strategy, an understanding of the tech and cannabis landscape and industry trends. Sullivan lives in New York City.

Connect: Linkedin.com/in/jeannemsullivan

Robert Jappie is a Partner at Fieldfisher LLP. He specialises in Life Sciences Regulation for the UK and Europe, providing advice and representation to a range of nascent industries in the Life Sciences sector. Robert advises businesses operating in highly regulated industries across the Life Sciences sector, with a particular focus on Healthcare, Plant-Based Therapies, Vaping, Food/Agri-Tech and Regulated Substances.

Robert is the leading legal authority on Cannabis in the UK. In addition to providing expert advice on all the day-to-day regulatory issues that Medical Cannabis companies face, he has advised on several Cannabis-related transactions in the UK, including Acquisitions, ECM, and POCA compliance matters.

Will Muecke is a co-founding managing member of Artemis Growth Partners, an ESG and impact-oriented private equity platform dedicated to investing 100% in the cannabis industry on a worldwide basis.

Artemis Growth Partners oversees US $400 million in mission-driven discretionary assets under management (AUM) invested in the global cannabis value chain, including branded products, distributors, value-added service providers, ancillary operators, and science-driven research and development platforms.

Will was co-founding managing partner of CoreCo Private Equity, a 2017 GIIRS-rated “Best for the World” ESG-focused impact fund backed by investors including the IFC/World Bank, and the multilateral/development banks of Germany, Norway, Switzerland, Belgium, the IADB, and UHNW individuals and European family offices (CoreCo was fully deployed as of July 2017).

Will was formerly the global co-head of the healthcare services sector in the healthcare investment banking group at Goldman, Sachs & Co. (New York).

Will maintains extensive personal and professional networks in Europe, US, and Latin America.

Will resides in London and is the Chief Investment Officer for Artemis Growth Partners.

Artemis Growth Partners website: www.artemisgrowth.com

Linkedin profile: www.linkedin.com/in/wmuecke/

Jon Robson is the Founder and CEO of Mamedica, the UK’s leading digital platform for medical cannabis. Under his leadership, Mamedica has scaled rapidly to serve thousands of patients nationwide, delivering clinically-led access to cannabis-based medicines. Mamedica was recently named one of Entrepreneur Magazine’s Top 100 London Startups, recognising its innovation, growth and impact on patient care. A vocal advocate for policy reform, Jon has contributed to leading reports including the London Drugs Commission’s “Cannabis Conundrum” and frequently engages with regulators, media and investors to drive the conversation forward.

Kai has been a business and corporate lawyer in Germany since 2003, gaining wide range of experiences in the process. He is very familiar with the interconnectivity between national and European regulations, especially in regard to consumer protection, product safety and emerging new cannabis products. He has engaged in advocacy relating to cannabis beginning in early stages of his studies at Philipps University Marburg when the German Supreme Court ruled that small amounts of cannabis should not be criminalized. After medical cannabis was legalized, Kai started a legal blog (canna-biz.legal) on all the relevant new developments in the emerging cannabis market and became a legal expert especially for CBD products. He regularly speaks at international cannabis conferences on topics of the German and European legal framework. Lastly he spoke at the ICBC 2021 in Berlin and Zurich, at the CB Expo 2021 in Zurich, at Re:publica in Berlin and EuroAMCBC in Prague on the legal framework for a future recreational cannabis market in Germany, at the First Asian Hemp Summit in Hong Kong and at the Cannabis Law Institute in New York. He has published articles at Prohibition Partners and in German law journals. Kai and his Law firm KFN+ consult major CBD and medical cannabis companies. Kai is also legal advisor to the European Industrial Hemp Association (EIHA), which is working on a Novel Food joint application for different CBD products.

Memberships: German Bar Association (DAV), International Cannabis Bar Association (INCBA, Member of Advisory Board), European Industrial Hemp Association (EIHA), German Hemp Association (DHV), Law Enforcement Against Prohibition (LEAP Germany), Branchenverband Cannabiswirtschaft (BvCW).

Born in Löhne/Westf. in 1972, studied law at the Universities of Marburg, Adelaide (Australia), Cologne, legal expert at the press center of the German Federal Diet, worked for the Berlin District Court, for the Director of Public Prosecution in Berlin, for the Office for the Protection of the Constitution and the Hong Kong Consulate General.

Peter Homberg specialises in life sciences, IP and corporate law, and M&A transactions.
He particularly advises companies in the pharmaceutical, diagnostics, medical device and biotechnology sectors on research and development contracts, collaboration agreements, cross-border IP licensing and IP strategies. He also has extensive experience in advising on compliance issues and advises companies extensively in the field of medical cannabis.
Peter is a frequent speaker at seminars and conferences and is the author of numerous articles and other publications on corporate or IP law in the areas of life sciences and medical cannabis. In addition, he has extensive transaction experience in Southeast Asia.
His clients include:
Start-ups
Medium-sized companies
Listed companies
Nationally and internationally operating corporate groups
Financial investors
Strategic investors

Experience Highlights
DEMECAN GmbH: Preparation of a legal opinion on the compatibility of the legalization of cannabis for recreational purposes in Germany with international and European law. Identification of possible solutions to overcome obstacles under international and European law.
Canopy Growth Corp.: Advising the subsidiary of one of Canada’s leading medical cannabis providers in connection with the acquisition of the Storz & Bickel GmbH & Co. KG group of companies for a total of €135 million.
DEMECAN GmbH: Preparation of a comprehensive legal opinion on the legal hurdles to the legalization of cannabis for recreational purposes and analysis of possible legal solutions.
Proteona Pte. Ltd.: Advising the biotechnology company on the conclusion of an exclusive worldwide license agreement with the National University of Singapore (NUS).
Canadian supplier of medical cannabis: Advising in connection with the conclusion of a joint venture agreement with a German wholesaler of pharmaceuticals.
Scil Technology GmbH: Advising on the out-licensing of a program for the regenerative treatment of osteoarthritis and cartilage defects to Sanofi.
Scil Technology GmbH: Advising on the sale of its service and production division to Nanohale AG.
German biotechnology company: Advising on the sale of a technology for the treatment of certain forms of heart failure.
German mid-sized pharmaceutical company: Advising on the out-licensing and distribution of an API for the treatment of interstitial cystitis to a US-based multinational pharmaceutical company.
Large US-based pharmaceutical company: Advising on the due diligence of a technology portfolio in advance of the in-licensing of a technology for the production of vaccines.
Swiss biotech company: Advising on a planned collaboration with a French multinational pharmaceutical company.
German-Singaporean biotech company: Advising on the in-licensing of a key diagnostic technology from the National University of Singapore.
French venture capital fund: Advising on the acquisition of a block of shares in a German biotech company.
Medium-sized pharmaceutical company: Advising on the restructuring of sales in Portugal and various other European countries.
Various clients: Advising in connection with transactions in the life sciences sector, including technology transfer agreements, research and development agreements, corporate transactions (mergers & acquisitions), private equity transactions, arbitration proceedings and litigation.

Gašper Friškovec is a licensed attorney in Slovenia, and has over a decade of practice in advising clients and their legal representation on economic, regulatory, and political matters before the highest Slovenian and international courts. He is a graduate of the Faculty of Law at the University of Ljubljana, where he is also earning his doctorate while specializing in administrative law. His experience has given him a unique perspective on public policy and law within both Slovenia and the EU. Gasper is able to work adeptly within a variety of regulatory frameworks. He brings a pragmatic and disruptive approach to crafting innovative solutions for the complex challenges facing businesses in this emerging industry.

Daniel Cook is a seasoned growth company leader with a track record of scaling businesses from early-stage to over $250 Million in enterprise value. He specializes in building high impact companies in emerging markets and breakthrough categories.

Daniel is currently CEO of True Companies (Trueco), a specialized flavor house with deep domain expertise in terpenes—the molecular building blocks behind more than $8 Billion in annual consumer product formulations across cannabis, beer, and CPG. Under his leadership, Trueco has grown EBITDA 10X and sales 4X in less than five years. [2020-Present]

Prior to Trueco, Daniel helped build Endeavor’s Global Entrepreneur Support Program. This program worked with the top high growth entrepreneurs in emerging markets across a variety of industries to help them refine their strategy, raise capital, forge partnerships and recruit talent. During his tenure, Endeavor helped to catalyze over $1.5 Billion in exits for founders in emerging markets. Today, Endeavor backs over 37 unicorns outside of China, making it the most active investor in billion-dollar scaleups in those regions. [1999-2002]

Daniel spent over six years in South America leading growth initiatives in the wine industry—first as a Fulbright Scholar in Chile, and later running commercial operations for Moët Hennessy’s Argentina portfolio, including Terrazas de los Andes (>200,000 cases sold/year) and Cheval des Andes, a joint venture with storied Premier Grand Cru Classe A – Chateau Cheval Blanc, both LVMH “Rising Star Brands.” [2004-2008]

Daniel has served as a founder, advisor, and board member to high-growth companies across cannabis, clean energy, regenerative agriculture, and natural products. He built Keen-Wah(+) Foods® a portfolio of consumer natural foods products that have been tested and approved by an avid community of 250,000 healthy living supporters and rolled out to thousands of points of sale (acq. by Nestlé Americas as a part of a multi-brand rollup). He also served as an Entrepreneur-in-Residence for Califia Farms, a pioneer in the plant-based dairy product category (almond) and innovator in plant-based milks, creamers, juices, and dairy-free probiotic yogurts, where he and helped bring to market natural products generating hundreds of millions in revenue. [2008-2020]

Daniel holds an MBA from Harvard Business School, where he received the Social Enterprise Scholarship for his work on venture capital in underserved communities, and was nominated for the Dean’s Award after leading the first private clean energy installation at Harvard. [2002-2004]

He earned a BA in Literature from Fairfield University, was awarded a Fulbright to Chile, and served as an Eisenhower Ambassador to the UK, Sweden, Finland, and Russia. [1992-1996].

Jamie Pearson has been a highly respected leader in the cannabis industry for over a decade. Her “in the trenches” operational success and deep, global relationships led her to be coined “Wonder Woman” in the 2023 Women of Influence issue of Cannabis Now Magazine. Fluent in German, Jamie spent decades in the global real estate investment and finance world on three continents. She currently sits on the advisory boards of Dope Drinks, Marley One, Cellotex Dev Ltd, Global Cannabis Network Collective (GCNC), Lift & Co, and Alpen Group AG.
Jamie founded and leads The New Holland Group, a global consulting firm serving clients with international business development & strategy, seed to sale operations, branding & marketing, effective capital raising, executive coaching, cross border IP licensing, celebrity partnerships, buy & sell side M&A, and financial turnarounds. Client referrals have been New Holland Group’s only source of business and business is booming!
Before New Holland Group, Jamie spent seven years, including three as the President & CEO, of Bhang Inc. [CSE:BHNG] one of the world’s most-awarded and recognized cannabis edible brands, famous for its infused chocolate bars. She led the company’s diverse executive team, managed the “expansion through licensing” plan, ran the capital markets division, and was the face of the brand – catapulting Bhang from a California favorite to a multi-state and multi-national phenomenon. When Jamie exited Bhang the brand had been distributed in 7 US states and 10 countries through licensing deals with the likes of Trulieve, [CSE:TRUL], Indiva [TSX:NDVA] and Origin House [CSE:OH] (now Cresco). Jamie served four years as the Vice Chairman of Bhang’s Board and served on the Board’s audit committee.
Jamie is a popular speaker with competence in the areas of global expansion, ESG, IP & brand licensing, real estate acquisition, creative deal structuring, celebrity partnerships, business development, and leadership. Jamie can be reached at jamie@new-holland.group.

Lisa Haag is an entrepreneur in the German cannabis industry. She holds a degree in business administration (IUBH, Bad Honnef) and a Bachelor of Business (Victoria University, Melbourne) in hospitality management. Lisa worked many years for companies in strategic and regional sales for FM-services (IFM, TFM, etc.).

Lisa has been active in the cannabis industry since 2017. In July 2018, she founded MJ_UNIVERSE GmbH, a publisher of digital products (e.g. Krautinvest.de) and a collaborative network to connect companies along the value chain of cannabis. She works with a network of specialised experts to consult companies looking to navigate the European cannabis ecosystem. As an entrepreneur, she is committed to projects dedicated to accelerate cannabis as a medicine, to advocacy for a more progressive and realistic cannabis regulatory framework and to activities to mainstream cannabis. With MJ_UNIVERSE, Lisa’s mission is to unlock the full potential of cannabis.

Lisa is part of the board of the BvCW e.V. and an active member of the Cannafem Network – a network for women, hemp and cannabis.

George Bellow is a visionary entrepreneur and strategic leader with over 16 years of experience in sales, business development, and startup growth across industries like pharmaceuticals, virtual reality, and fintech. As Co-Founder of SOMAÍ Pharmaceuticals, George successfully raised €30 million, playing a pivotal role in establishing the company’s sales and distribution networks across Europe. His work secured partnerships in key markets such as Germany, the UK, Switzerland, and Poland, positioning SOMAÍ as a leading name in the European medical cannabis sector.
Before SOMAÍ, George founded Belka VR, a trailblazing virtual reality company that gained global recognition. He also spearheaded international sales growth for UNICUM, expanding its reach to over 24 countries. In Russia, George co-founded Mili, a fintech pioneer in microloans, scaling it to become the largest provider in the country with over $13 million in revenue before a successful exit. His strategic foresight helped raise €5 million for Mili, fueling its rapid growth and market leadership.
With executive education from MIT Sloan and an MBA from Moscow School of Management Skolkovo, George brings unmatched expertise in strategic planning, capital raising, and business scaling, driving impactful results and innovation in every venture he leads.

Dirk Heitepriem is the Vice President Government Relations Europe, Australia and New Zealand at Aurora Europe, a subsidiary of Aurora Cannabis Inc., one of the global leaders in medicinal cannabis. In his role he is overlooking all activities regarding government relations and regulatory developments in more five core markets globally and other prospect countries in Europe.
Currently he is also the President / Chairman of the German Cannabis Industry Association (BvCW). In his role within the BvCW was deeply involved in the liberalisation of Cannabis in Germany.
He is involved in the Cannabis Industry since 2018.
For the last 15 year he worked in the field of Government Relations for Canadian companies like Canopy Growth and BlackBerry, dealing with countries across Europe, Africa and the Middle East.
Dirk studied Journalism and Public Relations in Hannover and worked in German Politics for several years.

Since starting his first company at the age of 22, Raj has established himself as one of Canada’s foremost business strategists and dealmakers. He is the founder of High Tide and its subsidiary companies Valiant Distribution and Canna Cabana and is the co-founder of High Tide’s subsidiary, Famous Brandz.

Through organic growth and strategic acquisitions, Raj has grown High Tide from one small shop of 2 employees in 2009 into Canada’s largest cannabis retailer with over 190 locations and over 1,600 amazing team members and business interests spanning North America and Europe.

While committed to building a strong, profitable, and sustainable business, Raj also believes passionately that those who enjoy success hold a particular responsibility to give back. In that vein, he spearheaded the launch of High Tide’s CSR program, Rising Tide for Good which has supported many worthy causes both cannabis-related and otherwise. On a personal level, Raj has also been a long-time supporter of Operation Smile, an organization that works to deliver free, safe cleft surgery to children in need, saving them from a lifetime of pain and isolation.

Chief Inspiration Officer – Sullivan Adventures LLC
Partner: New Holland Group
Keynote Speaker – Advisor – Investor

Jeanne M. Sullivan is a passionate about delivering ideas – information – and inspiration to entrepreneurs – Sullivan has been early to various sectors – investing in tech infrastructure, the internet wave, cloud-based computing, data aggregation and early in the cannabis sector. She is thrilled to leverage years in this industry and support entrepreneurs seeking European-based cannabis opportunities.
She co-founded an early-stage cannabis fund and is a frequent speaker on the conference circuit. Sullivan has been part of the Arcview Group and Arcview Ventures since 2015.

Jeanne co-founded StarVest Partners, a venture capital firm in NYC raising $400 million to invest in tech-enabled business services companies. Prior to her venture experience with StarVest and Olivetti Ventures, Jeanne gained her operating experience with AT&T and Bell Labs while serving in product and industry marketing roles.

Ms. Sullivan has served on the board of multiple technology and cannabis companies and has extensive experience creating “go to market” plans for growth and expansion stage companies. Her expertise also includes strategy, an understanding of the tech and cannabis landscape and industry trends. Sullivan lives in New York City.

Connect: Linkedin.com/in/jeannemsullivan

Dr. Dani Fadel is the President of the Lebanon Regulatory Authority for Medical and Industrial Cannabis. Dr. Fadel holds a Ph.D. in medicinal plants and the production of drugs from natural resources. Additionally, Dr. Dani Fadel holds three postdoctoral degrees, focusing respectively on cannabis, heavy metals, and the exploration of natural resources using advanced techniques, as well as a certificate in nanotechnology. With extensive experience in medicinal plants, active compounds, biotechnology, pharmacognosy, and cannabis-related industries, Dr. Fadel’s expertise spans a wide range of fields. As the President of the Lebanon Regulatory Authority for Medical and Industrial Cannabis, he leads the country’s national efforts to regulate cannabis cultivation, processing, and export in accordance with Law 178/2020. He has played a pivotal role in shaping Lebanon’s cannabis strategy, driving innovation, international collaboration, and sustainable agricultural development.

Rachel Wright, CPA, MST is a hands-on business leader, strategic thinker, and trusted financial partner with over a decade of experience in the cannabis industry — and another 10 years before that in real estate development and manufacturing. She founded Verdant Strategies in 2024, building on the legacy of 420CPA and AB FinWright LLP, which she co-founded in 2020.
Rachel’s work is rooted in one goal: helping cannabis operators grow stronger, more resilient businesses. From day one, she’s brought deep tax expertise and operational insight to an industry where the rules are constantly evolving. Whether guiding clients through cross-border compliance, navigating M&A, or building internal financial systems from the ground up, Rachel leads with clarity, precision, and a fierce commitment to her clients’ success.

She’s also been called in when the stakes are high. Rachel has supported operators through complex financial disputes, providing litigation support and expert witness testimony where transparency and sound accounting are critical. She served on the board of a public cannabis company in Canada, including as audit committee chair, bringing governance and financial oversight during a key phase of expansion.

Rachel works with clients across the U.S. and internationally, supporting operators in both established and emerging cannabis markets. Her perspective has been featured in Bloomberg Tax, MJBizDaily, The Cannabis Industry Journal, Marijuana Venture, and the LA Daily Journal. She has contributed her time and voice to industry organizations including the International Cannabis Bar Association (INCBA), the Cannabis Chamber of Commerce, and the Tri-State Cannabis Networking Group, and has spoken at events hosted by Benzinga, the Cannabis Quality Conference, INCBA, and NBI.

She holds a Master’s in Taxation and a Graduate Degree in International Taxation from Golden Gate University and is a licensed Certified Public Accountant (CPA).

George Bellow is a visionary entrepreneur and strategic leader with over 16 years of experience in sales, business development, and startup growth across industries like pharmaceuticals, virtual reality, and fintech. As Co-Founder of SOMAÍ Pharmaceuticals, George successfully raised €30 million, playing a pivotal role in establishing the company’s sales and distribution networks across Europe. His work secured partnerships in key markets such as Germany, the UK, Switzerland, and Poland, positioning SOMAÍ as a leading name in the European medical cannabis sector.
Before SOMAÍ, George founded Belka VR, a trailblazing virtual reality company that gained global recognition. He also spearheaded international sales growth for UNICUM, expanding its reach to over 24 countries. In Russia, George co-founded Mili, a fintech pioneer in microloans, scaling it to become the largest provider in the country with over $13 million in revenue before a successful exit. His strategic foresight helped raise €5 million for Mili, fueling its rapid growth and market leadership.
With executive education from MIT Sloan and an MBA from Moscow School of Management Skolkovo, George brings unmatched expertise in strategic planning, capital raising, and business scaling, driving impactful results and innovation in every venture he leads.

Will Muecke is a co-founding managing member of Artemis Growth Partners, an ESG and impact-oriented private equity platform dedicated to investing 100% in the cannabis industry on a worldwide basis.

Artemis Growth Partners oversees US $400 million in mission-driven discretionary assets under management (AUM) invested in the global cannabis value chain, including branded products, distributors, value-added service providers, ancillary operators, and science-driven research and development platforms.

Will was co-founding managing partner of CoreCo Private Equity, a 2017 GIIRS-rated “Best for the World” ESG-focused impact fund backed by investors including the IFC/World Bank, and the multilateral/development banks of Germany, Norway, Switzerland, Belgium, the IADB, and UHNW individuals and European family offices (CoreCo was fully deployed as of July 2017).

Will was formerly the global co-head of the healthcare services sector in the healthcare investment banking group at Goldman, Sachs & Co. (New York).

Will maintains extensive personal and professional networks in Europe, US, and Latin America.

Will resides in London and is the Chief Investment Officer for Artemis Growth Partners.

Artemis Growth Partners website: www.artemisgrowth.com

Linkedin profile: www.linkedin.com/in/wmuecke/

Chief Inspiration Officer – Sullivan Adventures LLC
Partner: New Holland Group
Keynote Speaker – Advisor – Investor

Jeanne M. Sullivan is a passionate about delivering ideas – information – and inspiration to entrepreneurs – Sullivan has been early to various sectors – investing in tech infrastructure, the internet wave, cloud-based computing, data aggregation and early in the cannabis sector. She is thrilled to leverage years in this industry and support entrepreneurs seeking European-based cannabis opportunities.
She co-founded an early-stage cannabis fund and is a frequent speaker on the conference circuit. Sullivan has been part of the Arcview Group and Arcview Ventures since 2015.

Jeanne co-founded StarVest Partners, a venture capital firm in NYC raising $400 million to invest in tech-enabled business services companies. Prior to her venture experience with StarVest and Olivetti Ventures, Jeanne gained her operating experience with AT&T and Bell Labs while serving in product and industry marketing roles.

Ms. Sullivan has served on the board of multiple technology and cannabis companies and has extensive experience creating “go to market” plans for growth and expansion stage companies. Her expertise also includes strategy, an understanding of the tech and cannabis landscape and industry trends. Sullivan lives in New York City.

Connect: Linkedin.com/in/jeannemsullivan